Annual Total Long Term Liabilities
$4.76 M
+$2.43 M+104.64%
December 31, 2021
Summary
- As of February 10, 2025, SBTX annual total long term liabilities is $4.76 million, with the most recent change of +$2.43 million (+104.64%) on December 31, 2021.
- During the last 3 years, SBTX annual total long term liabilities has fallen by -$52.62 million (-91.70%).
Performance
SBTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$4.07 M-100.00%
September 30, 2022
Summary
- As of February 10, 2025, SBTX quarterly total long term liabilities is $0.00, with the most recent change of -$4.07 million (-100.00%) on September 30, 2022.
- Over the past year, SBTX quarterly long term liabilities has dropped by -$5.08 million (-100.00%).
Performance
SBTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SBTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +104.6% | -100.0% |
| 3 y3 years | -91.7% | -100.0% |
| 5 y5 years | -91.7% | -100.0% |
SBTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -100.0% | at low |
| 5 y | 5-year | -91.6% | -51.1% | -100.0% | at low |
| alltime | all time | -91.7% | -51.1% | -100.0% | at low |
Silverback Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $4.07 M(-8.3%) |
| Mar 2022 | - | $4.43 M(-6.9%) |
| Dec 2021 | $4.76 M | $4.76 M(-6.3%) |
| Sep 2021 | - | $5.08 M(+185.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $1.78 M(-13.5%) |
| Mar 2021 | - | $2.06 M(-11.7%) |
| Dec 2020 | $2.33 M(-95.9%) | $2.33 M(-98.9%) |
| Sep 2020 | - | $219.16 M(+287.9%) |
| Dec 2019 | $56.50 M(-1.5%) | $56.50 M |
| Dec 2018 | $57.38 M | - |
FAQ
- What is Silverback Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Silverback Therapeutics?
- What is Silverback Therapeutics annual total long term liabilities year-on-year change?
- What is Silverback Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Silverback Therapeutics?
- What is Silverback Therapeutics quarterly long term liabilities year-on-year change?
What is Silverback Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SBTX is $4.76 M
What is the all time high annual total long term liabilities for Silverback Therapeutics?
Silverback Therapeutics all-time high annual total long term liabilities is $57.38 M
What is Silverback Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SBTX annual total long term liabilities has changed by +$2.43 M (+104.64%)
What is Silverback Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SBTX is $0.00
What is the all time high quarterly long term liabilities for Silverback Therapeutics?
Silverback Therapeutics all-time high quarterly total long term liabilities is $219.16 M
What is Silverback Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SBTX quarterly total long term liabilities has changed by -$5.08 M (-100.00%)